Moreover, studies have indicated that FSH exerts similar effects on ovarian cancer cells as on follicular development, promoting key cancerous processes such as proliferation, migration, invasion, and angiogenesis (Li et al., 2007; Stilley et al., 2014; Liu et al., 2015). This evidence concerns the gene BRD2 and ovarian cancer.